 |
|
|
|
 |
|
|
| Article 1 to 6 out of 6 concerning Erasmus Medical Center
|
-
New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications
(20 Nov 2009)
Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension and associated vascular complications such as heart and ...
-
Scientists Discover New Molecular Markers for Testicular Cancer
(18 Oct 2007)
Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells
Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems, an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific ...
-
European expert consortium combines forces to develop a novel pandemic influenza vaccine
(28 Sep 2007)
A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The four-year project has been awarded a grant of EUR3.5 ...
-
OncoMethylome Publishes Positive Clinical Trial Results for Urine-based Bladder Cancer Test
(19 Sep 2007)
OncoMethylome Sciences published interim data from its ongoing bladder cancer clinical trial. The trial results showed that the urine test that OncoMethylome is developing can successfully detect bladder cancer, especially when the cancer is in ...
-
DNage, Loders Croklaan, BG Medicine and Erasmus announce collaboration in the field of type II diabetes
(02 May 2006)
DNage BV, Loders Croklaan BV, through its wholly owned subsidiary Lipid Nutrition BV ("Lipid Nutrition"), BG Medicine Inc ("BG Medicine") and the Erasmus University Medical Center ("Erasmus MC") announced the start of a collaboration to develop new ...
-
DakoCytomation and ViroNovative enter licensing agreement on Human Metapneumovirus
(09 May 2005)
DakoCytomation A/S and ViroNovative BV have entered into a licensing agreement for the development and sales of diagnostic products for the detection of Human Metapneumovirus.Human metapneumovirus was discovered by a team of scientists led by Prof. ...
|
|
|
|
|
Top